Showing 6,021 - 6,040 results of 16,418 for search '"Therapy"', query time: 0.10s Refine Results
  1. 6021

    Evaluation of Oral Cannabinoid-Containing Medications for the Management of Interferon and Ribavirin-Induced Anorexia, Nausea and Weight Loss in Patients Treated for Chronic Hepati... by Cecilia T Costiniuk, Edward Mills, Curtis L Cooper

    Published 2008-01-01
    “…OBJECTIVES: The systemic and cognitive side effects of hepatitis C virus (HCV) therapy may be incapacitating, necessitating dose reductions or abandonment of therapy. …”
    Get full text
    Article
  2. 6022

    Immunosuppression and the Immune Response to Transplantation by David Ludwin, Dianne Arlen, J David Russell

    Published 1993-01-01
    “…OBJECTIVES: To review the roles of allorecognition, transplant rejection, and immunosuppressive therapy in predisposing patients to viral infections. …”
    Get full text
    Article
  3. 6023

    Nitric Oxide Levels in Patients with Psoriasis Treated with Methotrexate

    Published 2006-01-01
    “…In this study, 22 patients with psoriasis were scored with PASI (psoriasis area and severity index) and the levels of serum nitrite-nitrate were evaluated before and after therapy with methotrexate (Mtx). The results were compared with age- and sex-matched healthy volunteers. …”
    Get full text
    Article
  4. 6024

    Cytomegalovirus and Human Herpesvirus 6 and 7: Diseases and Diagnosis in Transplantation by Paul D Griffiths

    Published 1993-01-01
    “…Patients with active infection can then be entered into trials of suppressive therapy (where virus excretion is from the urine or saliva) or pre-emptive therapy (where excretion is detected systemically). …”
    Get full text
    Article
  5. 6025

    Antidepressant Prophylaxis Reduces Depression Risk but Does Not Improve Sustained Virological Response in Hepatitis C Patients Receiving Interferon Without Depression at Baseline:... by Awad Al-Omari, Juthaporn Cowan, Lucy Turner, Curtis Cooper

    Published 2013-01-01
    “…BACKGROUND: Depression complicates interferon-based hepatitis C virus (HCV) antiviral therapy in 10% to 40% of cases, and diminishes patient well-being and ability to complete a full course of therapy. …”
    Get full text
    Article
  6. 6026
  7. 6027
  8. 6028

    The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma by O. A. Storonova, A. V. Paraskevova, A. A. Makushina

    Published 2024-08-01
    “…The addition of UDCA drugs to the basic therapy is pathogenetically justified in patients with GERD in the presence of duodenogastroesophageal reflux. …”
    Get full text
    Article
  9. 6029

    Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP by Tomohiro Kadota, Sachiko Seo, Hiroe Fuse, Genichiro Ishii, Kuniaki Itoh, Tomonori Yano, Kazuhiro Kaneko, Kunihiro Tsukasaki

    Published 2019-03-01
    “…Abstract Standard therapy for gastric diffuse large B‐cell lymphoma (DLBCL) is considered to be chemotherapy with or without involved‐field radiation therapy. …”
    Get full text
    Article
  10. 6030

    Percutaneous Vertebroplasty and Facet Blocking for Treating Back Pain Caused by Osteoporotic Vertebral Compression Fracture by Yongquan Cheng, Xiaoliang Wu, Jiawei Shi, Hui Jiang

    Published 2020-01-01
    “…Percutaneous vertebroplasty (PVP) and facet blocking (FB) combined therapy would relieve pain better, but it has not been elucidated. …”
    Get full text
    Article
  11. 6031

    Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center by Roxana Matran, Andra-Mihaela Diaconu, Andreea Maria Iordache, Irina Dijmărescu, Alexandra Coroleucă, Daniela Păcurar, Cristina Becheanu

    Published 2025-01-01
    “…This study aims to evaluate and document these AEs to facilitate optimal patient selection and monitoring strategies of patients undergoing these therapies. <b>Methods</b>: This retrospective, single-center study examined pediatric IBD patients receiving anti-TNF-α therapy at the “Grigore Alexandrescu” Emergency Hospital for Children in Bucharest, Romania, from January 2015 to October 2024. …”
    Get full text
    Article
  12. 6032
  13. 6033
  14. 6034

    Virological and Immunological Aspects of AIDS Pathogenesis by Brian Conway, Francisco J Diaz-Mitoma

    Published 1994-01-01
    “…In a large American clinical trial. resistance to zidovudine (ZDV) was predictive of subsequent disease progression if this therapy was continued. Surprisingly. this was also predictive of deterioration if therapy was changed to didanosine (ddl). …”
    Get full text
    Article
  15. 6035

    Delayed PCI 12 Hours after the Onset of Symptoms Is Associated with Improved Outcomes for Patients with ST-Segment Elevation Myocardial Infarction: A Real-World Study by Wen-Juan Xiu, Hai-Tao Yang, Ying-Ying Zheng, Yi-Tong Ma, Xiang Xie

    Published 2019-01-01
    “…The purpose of this study was to compare delayed PCI and medication therapy beyond the recommended time window of 12 h after the onset of symptoms on the outcomes of STEMI patients. …”
    Get full text
    Article
  16. 6036
  17. 6037

    Prognosis and cardiotoxicity associated to adjuvant trastuzumab for breast cancer: real world study in a public health system by Ana Elisa Ribeiro da Silva Cabello, César Cabello, Susana Oliveira Botelho Ramalho, Otávio Rizzi Coelho, Otávio Rizzi Coelho-Filho, Helymar da Costa Machado, Délio Marques Conde, Luiz Carlos Zeferino

    Published 2025-01-01
    “…Methods: This was a retrospective cohort study that included 255 HER2-positive breast cancer patients who received adjuvant trastuzumab therapy. The inclusion criteria were a diagnosis of HER2-positive breast cancer and adjuvant trastuzumab therapy; disease stage I-III; <70 years; and a baseline echocardiogram showing a left ventricular ejection fraction (LVEF) ≥ 55%. …”
    Get full text
    Article
  18. 6038

    Helicobacter pylori infection diagnostics and choice of eradication treatment: results of inquiry of doctors from different regions of Russian Federation by N. N. Dekhnich, R. S. Kozlov, O. A. Sablin, Ye. A. Prischepova

    Published 2018-08-01
    “…At the choice of second line antihelicobacter therapy mode components 34.8% of doctors complied to RGA guidelines. …”
    Get full text
    Article
  19. 6039

    Descriptive retrospective cross-sectional study of rehabilitation care for poststroke users in Québec during the COVID-19 pandemic by Palak Vakil, Perrine Ferré, Johanne Higgins, Louis-David Beaulieu, Marie-Helene Milot, Marie-Hélène Boudrias

    Published 2025-01-01
    “…Demographic characteristics were collected, as well as indicators routinely collected in acute care and rehabilitation such as length of stay (LOS), the Functional Independence Measure and a number of physical/occupational therapy (PT/OT) sessions. Non-parametric statistical tests were used to compare variables among the three groups.Results COV+ users were older than COV− and pre-COV ones (p&lt;0.01) and were more disabled on admission to a rehabilitation centre (p&lt;0.01). …”
    Get full text
    Article
  20. 6040

    Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development by Rachel A. Giese, Merit Turner, Mario Cleves, J. Reed Gardner, Gresham T. Richter

    Published 2021-01-01
    “…Monthly heights and weights of children undergoing propranolol therapy for IH were prospectively collected and tabulated. …”
    Get full text
    Article